Panadol Trio 250 mg / 250 mg / 65 mg

Panadol Trio 250 mg / 250 mg / 65 mg is a medicine authorised by Swissmedic under authorisation number 69036. The authorisation holder is Haleon Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 January 2025 and the authorisation is limited until 20 January 2030. ATC code N02BE51 places the medicine in the group Analgesics.

  • Dispensing category B
  • Authorisation number 69036
  • ATC N02BE51
  • Synthetic medicines
Authorisation data
Authorisation number69036
NamePanadol Trio 250 mg / 250 mg / 65 mg
Full namePanadol Trio 250 mg / 250 mg / 65 mg, Filmtabletten
Authorisation holderHaleon Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN02BE51
First authorisation21 January 2025
Authorisation validity20 January 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Panadol Trio 250 mg / 250 mg / 65 mg, FilmtablettenB21 January 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110Tablette(n)N02BE5101.01.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Panadol Trio 250 mg / 250 mg / 65 mg authorised in Switzerland?

Yes. Panadol Trio 250 mg / 250 mg / 65 mg is authorised by Swissmedic under authorisation number 69036, data as of 01 September 2026. The authorisation is limited until 20 January 2030.

Which dispensing category does Panadol Trio 250 mg / 250 mg / 65 mg have?

Panadol Trio 250 mg / 250 mg / 65 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Panadol Trio 250 mg / 250 mg / 65 mg?

The authorisation holder is Haleon Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com